Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile

被引:7
|
作者
Brebi, Priscilla [1 ,2 ]
Gloria Ili, Carmen [1 ,2 ]
Andana, Alejandra [1 ,2 ]
Menzel, Doris [1 ,2 ]
Lopez, Jaime [1 ,2 ]
Guzman, Pablo [1 ]
Melo, Angelica [2 ]
Buchegger, Kurt [1 ,2 ]
Roa, Juan C. [3 ,4 ]
机构
[1] Univ La Frontera, Fac Med, Dept Anat Patol, Lab Patol Mol, Casilla 54-D, Temuco, Chile
[2] Univ La Frontera, Ctr Excelencia Med Traslac Sci & Technol Bioresou, Casilla 54-D, Temuco, Chile
[3] Pontificia Univ Catolica Chile, Sch Med, Dept Pathol, Marcoleta 377,7th Floor, Santiago, Chile
[4] Millennium Inst Immunol & Immunotherapy P09 016 F, Adv Ctr Chron Dis ACCDiS, Santiago, Chile
关键词
Human papillomavirus; Cervical intraepithelial neoplasia; Cervical cancer; Polymerase chain reaction; Reverse line blotting assay; HYBRID-CAPTURE-II; HPV TYPES; NATURAL-HISTORY; VIRUS; PREVALENCE; LESIONS; IDENTIFICATION; EPIDEMIOLOGY; WORLDWIDE; INFECTION;
D O I
10.1186/s12885-017-3496-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) is the etiological factor for cervical cancer and its precursor lesions. The characterization of HPV genotypes in preneoplastic lesions and cervical cancer could establishes the effectiveness of vaccination plan in Chilean population. The aim of this study was to determine HPV frequency in a group of women including in a cervical screening program in the public health care system in Chile. Methods: We analyzed 985 cervical smears samples from women with different histological diagnosis, attending to public health care in Temuco-Chile between 2004 and 2012, to detect HPV genotypes, through PCR followed by reverse line blotting assay. Results: HPV was found present in 80.8% (n = 796) of samples. Only a 5.6% of 985 samples were infected with a low-risk HPV, considering multiple infections. 10.5% (n = 8/76) of normal cervical epithelia, 83.5% (n = 208/249) and 87.6% (n = 557/636) of low and high grade squamous intraepithelial lesions, respectively, and 95.8% (n = 23/24) of squamous cervical carcinomas tested positive for HPV. HPV 16 was the most frequent genotype found (Overall 44.9%, n = 442/985; SCC: 62.5%, n = 15/24). A high variability of HPV types was also found in preneoplastic lesions, whereas there was a selection of genotypes in neoplasia. Also, there was a higher risk of infection with HPV 16 in women <= 26 years and 34-41 years old (p < 0.05), meanwhile infections with HPV 16 or HPV 18 have related with cancer development (p < 0.01). Conclusions: These data provide further information about the frequency of HPV genotypes in women with cervical lesions in Chile, and the introduction of new targeted vaccines against a wider spectrum of HPV is suggested.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Human Papillomavirus Prevalence in Paired Urine and Cervical Samples in Women Invited for Cervical Cancer Screening
    Burroni, Elena
    Bonanni, Paolo
    Sani, Cristina
    Lastrucci, Vieri
    Carozzi, Francesca
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (03) : 508 - 515
  • [32] Cervical human papillomavirus screening among older women
    Grainge, MJ
    Seth, R
    Guo, L
    Neal, KR
    Coupland, C
    Vryenhoef, P
    Johnson, J
    Jenkins, D
    EMERGING INFECTIOUS DISEASES, 2005, 11 (11) : 1680 - 1685
  • [33] Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations
    Cannizzaro, Nancy T.
    Mittman, Brian S.
    Hahn, Erin E.
    Ngo-Metzger, Quyen
    Gould, Michael K.
    Hsu, Chunyi
    Shen, Ernest
    Tewari, Devansu
    Chao, Chun R.
    JOURNAL OF WOMENS HEALTH, 2024, 33 (12) : 1614 - 1624
  • [34] Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
    Laurie W Smith
    Fareeza Khurshed
    Dirk J van Niekerk
    Mel Krajden
    Sandra B Greene
    Suzanne Hobbs
    Andrew J Coldman
    Eduardo L Franco
    Gina S Ogilvie
    BMC Public Health, 14
  • [35] Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
    Smith, Laurie W.
    Khurshed, Fareeza
    van Niekerk, Dirk J.
    Krajden, Mel
    Greene, Sandra B.
    Hobbs, Suzanne
    Coldman, Andrew J.
    Franco, Eduardo L.
    Ogilvie, Gina S.
    BMC PUBLIC HEALTH, 2014, 14
  • [36] Multiple human papillomavirus genotypes in cervical samples of Dutch women participating in the national screening program
    Boon, M.
    Boon, L.
    Korporaal, H.
    ACTA CYTOLOGICA, 2007, 51 (02) : 281 - 282
  • [37] Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile
    Balanda, Monserrat
    Fernandez, Jorge
    Vergara, Nicolas
    Campano, Constanza
    Arata, Loredana
    San Martin, Hector
    Ramirez, Eugenio
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2019, 208 (06) : 757 - 771
  • [38] Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile
    Monserrat Balanda
    Jorge Fernández
    Nicolás Vergara
    Constanza Campano
    Loredana Arata
    Héctor San Martín
    Eugenio Ramírez
    Medical Microbiology and Immunology, 2019, 208 : 757 - 771
  • [39] Knowledge of Human Papillomavirus and Cervical Cancer among Women Attending Gynecology Clinics in Pretoria, South Africa
    Tiiti, Teboho Amelia
    Bogers, Johannes
    Lebelo, Ramokone Lisbeth
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (07)
  • [40] Preferences for Human Papillomavirus Testing with Routine Cervical Cancer Screening in Diverse Older Women
    Alison J. Huang
    Eliseo J. Pérez-Stable
    Sue E. Kim
    Sabrina T. Wong
    Celia P. Kaplan
    Judith M. E. Walsh
    A. Yuri Iwaoka-Scott
    George F. Sawaya
    Journal of General Internal Medicine, 2008, 23